Interrogation of bone marrow samples from newly diagnosed CML patients against control patients with idiopathic thrombocytopenic purpura showed an increase in KDM6A mRNA expression associated with CML (Figure 1I and Table S1). This evidence concerns the gene KDM6A and chronic myelogenous leukemia, BCR-ABL1 positive.